Navigation Links
CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007
Date:10/16/2007

es to hospitals and hospital-based physician practices in the United States. The company utilizes secure Internet technologies combined with its global-based delivery model to deliver its service and product offerings to healthcare providers.

Since it was founded in 1998, CBaySystems has been acknowledged by some of the industry's leading publications and ratings institutions, including Forbes.com - Ten to Watch, Healthcare Informatics 100, Deloitte Technology Fast 500, and Inc. Magazine -One of the Fastest Growing Privately Held Companies in America.

CBay is headquartered in Annapolis, MD, and Atlanta, GA. CBaySystems Holdings Ltd joined the AIM market of the London Stock Exchange on June 18, 2007 and trades under the ticker symbol CBAY. For more information, visit http://www.cbaysystems.com.

For additional information, please contact:

Stacey Cassidy

Director of Marketing

410.940.6900 x 3195

scassidy@cbaysystems.com


'/>"/>
SOURCE CBaySystems
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WHO Gives Its Approval For Bird Flu Test Kit
2. Microchip gives blind a chance of sight
3. Microchip gives blind a chance of sight
4. Combined scan gives exact cancer diagnosis
5. Tennis gives protection against heart disease lifelong
6. Camera gives hope for detection of breast cancer
7. Pancreas transplant gives hope to type 2 diabetes
8. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
9. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
10. FDA gives “black box warning” against three asthma drus
11. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ican women using Carraguard had no decrease in inf...4 (HealthDay News) -- A microbicidal vaginal gel c...fection. , That,s the conclusion of a study tha...gative women at three sites in South Africa. , ...o gel and told to use one applicator of gel and a ...
(Date:12/4/2008)..., Dec. 4 Aurora Health Care is ram... D supplements. Aurora,s Care Management,Clinical...ucate all Aurora,caregivers about the benefits of...g evidence that higher Vitamin D levels may improv...porosis, certain muscle conditions and,seasonal d...
(Date:12/4/2008)...N, Dec. 4 The U.S. Gove...Development (USAID), is providing an additional $6...abwe. This assistance is in addition to the $4 mi...gram USAID is already implementing in Zimbabwe. ,... working alongside the international community to ...
(Date:12/4/2008)...cts similar to those seen with standard dose of da...c. 4 (HealthDay News) -- A high dose of the chemot...tients with previously untreated acute myeloid leu...red by the U.S. National Cancer Institute (NCI) sh...row. This study included 633 patients, aged 16 to ...
Breaking Medicine News(10 mins):Health News:Experimental Vaginal Gel Doesn't Ward Off HIV 2Health News:Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D 2Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2
...estate investor John Sundahl has announced that he... Sundahl, a recovering alcoholic, said that his ro...Alcoholics Anonymous meeting in Los Angeles. He ...pears also loved him, and corroborated his claim b...
...ey known for her underwear antics display in the p... public while a real estate investor claims he is ...evealing herself bit by bit. With her new single s...a ball in the public and not too long back she was...
... dating, blind dates and the web are all pass, for...bination of smoking and flirting. This new trend...now experience new social encounters when going ou... This blend of smoking and flirting developed in t...
...ana, A Buddhist food festival was recently organis...urely and strictly zhai ci, or the pure vegetarian... of the Majestic Park Plaza, said: "At an average,... food festivals in a month. At some point of time,...
Other Medicine News:
(Date:12/2/2008)...ratories, a leading clinical-diagnostics and biom...ogy and allergy assays, announced that it has laun...nts whose immune systems may be compromised due to... drugs, or because they are taking immuno-suppress...e company launched the two new assays, the T Cell...
(Date:12/2/2008)...Therapeutics, Inc., a,privately held biopharmaceu...hase 3 trials evaluating its lead investigational ...ints. HZT-501, a novel, proprietary fixed-dose,co...ine, demonstrated a,statistically significant red...lammatory drug (NSAID)-induced upper gastrointesti...
(Date:12/1/2008)...w research has found that the availability of a po...r in an emergency room can significantly increase ...ally life-saving treatment. Results of the study, ...em Hospital in Salem, Mass., will be presented tod...ty of North America (RSNA). , , "The hospit...
(Date:12/1/2008)... -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) r...ld,s leading medical journals, results of clinical...ntal compound tasimelteon (VEC-162). The publicat...agonist tasimelteon (VEC-162) for transient insomn...ed multicentre trials." Results are reported from ...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Caregivers Protest Statewide to Stop Daughters of Charity From Silencing the Voice of Caregivers 26 Threatening Patient Care 23128 1Caregivers Protest Statewide to Stop Daughters of Charity From Silencing the Voice of Caregivers 26 Threatening Patient Care 23128 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 1Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 4SXC Health Solutions announces informedRx renewal contract with The University of Michigan 23122 1SXC Health Solutions announces informedRx renewal contract with The University of Michigan 23122 2Breastfeeding com Launches First Ever Social Network for Birth Related Medical Professionals 23118 1Breastfeeding com Launches First Ever Social Network for Birth Related Medical Professionals 23118 2
...IDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ ...m the first of two,Phase 3 clinical studies to ass...n investigational, non-antibiotic, polymer,therapy...d diarrhea,(CDAD). The second Phase 3 study of tol...pected later this year. , In this first Phase 3 st...
..., Switzerland--(BUSINESS WIRE)--Jul 9, 2007 - ZIOP...positive interim data,from an ongoing phase II tri...treat advanced sarcoma patients was presented at t...ting held July 5-8,2007 in Lugano, Switzerland. T...O-201) In Advanced Sarcoma," was presented by,Rash...
Other Medicine Technology:Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem.
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem.
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat
Medicine Products: